Systemic amyloidoses are protein misfolding disorders that cause amyloid deposits in organs like the heart, kidneys, and nervous system, leading to dysfunction. AL amyloidosis, which affects 3,500 to...
CURATED BY: Tanya Geist, RPA-C
Tanya Geist,
RPA-C Physician Associate, DENT Neurologic Institute
Understanding Antibodies in Myasthenia Gravis is Key to Accurate Diagnosis and Personalized Treatment
Myasthenia gravis (MG) is an autoimmune disorder where antibodies target the neuromuscular junction, causing muscle weakness and fatigue. Affecting 40-180...
Tanya Geist,
RPA-C Physician Associate, DENT Neurologic Institute
Multifocal Motor Neuropathy: Early Diagnosis and Treatment Prevent Long-Term Disability
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy that affects peripheral nerves and roots, with higher incidence in older...
Tanya Geist,
RPA-C Physician Associate, DENT Neurologic Institute
New Staging System for Managing Primary Progressive Aphasias
Primary progressive aphasias (PPA) are neurodegenerative dementias marked by language impairments and are a significant cause of dementia in younger...
Kelly Papesh,
DNP, APRN, FNP-C Nurse Practitioner, Association of Movement Disorder APPs
Effective Biomarkers That Differentiate Motor Neuron Disease From Multifocal Motor Neuropathy
A recent study assessed the effectiveness of serum neurofilament light chain (NfL) and cerebrospinal fluid (CSF) phosphorylated neurofilament heavy chain...
Jerrica R. Farias,
MN, ARNP, PMHNP-BC Nurse Practitioner, Associate Director of USF ALS Clinic at University of South Florida
